The Controversial Alzheimer's Drug. Aducanumab (Aduhelmâ„¢) has received accelerated approval as a treatment for Alzheimer's disease from the U.S. Food and Drug Administration (FDA).

Save
2 years ago
13
News Trending News Alzheimer's Drug Viral

The FDA’s approval of Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph. But the excitement around the drug has receded. Why is Biogen’s drug so controversial?

Loading comments...